Bulletin from the Annual General Meeting of ContextVision AB (publ) on 14 May 2024

ContextVision (publ), org. no. 556377-8900 (the "Company"), held its Annual General Meeting on May 14, 2024, at 13:00 at the company headquarters at Holländargatan 13, 113 36 Stockholm.  Major items approved by the Annual General Meeting include the below.

Adoption of the accounts

The Annual General Meeting approved the Company's income statement and balance sheet for 2023. The Board members and the Managing Director were discharged from liability for the fiscal year 2023.

Disposition of profits
The Annual General Meeting resolved, in accordance with the Board's proposal, that this year's results shall be carried forward.

• The annual financial report regarding 2023 was approved by the AGM.
• Disposition of financial results according to the proposal of the Board of Directors was approved.

Board and auditor fees

• The Remuneration report for the Board of Directors and senior executives was approved.

• Board compensation was decided according to the following:
  • The chairman of the board will be paid SEK 385.000 (previously 350.000) for the period until next AGM.
  • Other members of the board will be paid SEK 253.000 (previously 230.000 for a board member who is not also a main shareholders) for the period until next AGM.
• The audit fee will be based on current account.

Board of Directors and auditor

It was approved that the number of board members should be 4, and the number of deputies should be 0.

• Olof Sandén, Martin Hedlund, Sven Günther-Hanssen and Martin Ingvar were reelected as board members. Olof Sandén was re-elected as chairman of the board.
• No deputy members were elected.

Grant Thornton was re-elected as auditor for the coming year, with acting auditor Joakim Söderin.

För ytterligare information, vänligen kontakta:

Richard Hallström, CFO
[email protected]

About ContextVision

ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.